Katherena Vermette

Recent publications · Crossref

5 total works indexed

1. Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer

   · 2010 · cited 414x

2. Bioreactors for tissue mass culture: Design, characterization, and recent advances

   · 2005 · cited 312x

3. A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors

   · 2009 · cited 233x

4. Interactions of phospholipid- and poly(ethylene glycol)-modified surfaces with biological systems: relation to physico-chemical properties and mechanisms

   · 2003 · cited 205x

5. Bacterial cellulose: A comprehensive review

   · 2024 · cited 169x

via Crossref · CC0